15.07.2016 - A US federal judge has set Jun. 26, 2017 as the trial date for Martin Shkreli, the 33-year-old founder of Retrophin and Turing Pharmaceuticals and former CEO of KalaBios as well as...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)